Cibc World Markets Corp Drug Manufacturers

Cibc World Markets Corp

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
ZTS Zoetis Inc.	$70.1B	$8.74 Million 0.06% of portfolio	56,059	Q2 2025 Added 3.5%
VTRS Viatris Inc	$12.3B	$882,000 0.01% of portfolio	98,820	Q2 2025 Reduced 31.36%
LNTH Lantheus Holdings, Inc.	$3.71B	$680,000 0.0% of portfolio	8,319	Q2 2025 Reduced 45.56%
ALKS Alkermes Plc.	$4.49B	$571,000 0.0% of portfolio	19,992	Q2 2025 Reduced 44.05%
NBIX Neurocrine Biosciences Inc	$12.3B	$517,000 0.0% of portfolio	4,120	Q2 2025 Reduced 10.57%
PBH Prestige Consumer Healthcare Inc.	$3.25B	$486,000 0.0% of portfolio	6,098	Q2 2025 Reduced 44.52%
SUPN Supernus Pharmaceuticals, Inc.	$2.21B	$209,000 0.0% of portfolio	6,648	Q2 2025 Reduced 40.34%
AMRX Amneal Pharmaceuticals, Inc.	$1.37B	$150,000 0.0% of portfolio	18,542	Q2 2025 Reduced 47.49%
DVAX Dynavax Technologies Corp	$1.34B	$128,000 0.0% of portfolio	12,964	Q2 2025 Reduced 55.65%
AQST Aquestive Therapeutics, Inc.	$202M	$35,000 0.0% of portfolio	10,601	Q2 2025 Reduced 35.67%
ESPR Esperion Therapeutics, Inc.	$119M	$24,000 0.0% of portfolio	24,604	Q2 2025 Reduced 41.32%
IRWD Ironwood Pharmaceuticals Inc	$150M	$14,000 0.0% of portfolio	19,714	Q2 2025 Reduced 37.2%

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

Stay updated on Cibc World Markets Corp with notifications on news.